Douglas Dong Fang

7 Patents

• US123701972025

  Combination Product of a Bcl-2/bcl-xl Inhibitor and a Chemotherapeutic Agent and Use Thereof in the Prevention And/or Treatment of Diseases

  ASCENTAGE PHARMA GROUP Corp LIMITED

  0 cites
• US122873382025

  Method and Compositions for Predicting Anti-cancer Efficacy of Compounds Targeting Apoptosis Pathway

  Ascentage Pharma Group Corp Limited

  0 cites
• US122686652025

  Combination of Immunotherapies with MDM2 Inhibitors

  ASCENTAGE PHARMA (SUZHOU) CO., Ltd

  0 cites
• US122330472025

  Pharmaceutical Combination and Use Thereof

  ASCENTAGE PHARMA GROUP Corp LIMITED

  0 cites
• US121940242025

  Pharmaceutical Composition of MDM2 Inhibitor and Use Thereof for Preventing And/or Treating Disease

  ASCENTAGE PHARMA GROUP Corp LIMITED

  0 cites
• US121863042025

  Method for Treating Cancer by Combination of IAP Inhibitor and Modulator of Immune Checkpoint Molecule

  Ascentage Pharma (Suzhou) Co., Ltd.

  0 cites
• US120831362024

  Combination of BCL-2/BCL-XL Inhibitors and Chemotherapeutic Agent and Use Thereof

  ASCENTAGE PHARMA (SUZHOU) CO., Ltd

  0 cites